Evidence review · Published July 22, 2026 · Sources checked July 22, 2026

KPV research overview

KPV is the Lys-Pro-Val tripeptide corresponding to residues 11–13 at the C-terminus of alpha-melanocyte-stimulating hormone (alpha-MSH).

Evidence boundary: published research does not establish the identity or performance of a separately supplied batch. The catalog product is supplied only for qualified in vitro laboratory research and is not for human or animal use.

What is KPV?

Research has examined epithelial transport, inflammatory signaling, and delivery systems in cultured cells and mouse models.

Research category

Tissue & cellular signaling

Study models represented

Human cell lines and mouse inflammation models

Names in the literature

Lys-Pro-Val; alpha-MSH(11-13)

Primary boundary

Carrier-dependent cell and mouse results do not establish human efficacy or product interchangeability.

What does the selected evidence support?

The selected evidence is preclinical and often depends on specialized carriers or disease models. It cannot establish outcomes for an unformulated research material.

Primary sources

1. Dalmasso et al., Gastroenterology (2008) — PepT1-mediated uptake and anti-inflammatory observations in cell and mouse colitis models. DOI: 10.1053/j.gastro.2007.10.026
2. Xiao et al., Biomaterials (2017) — Hyaluronic-acid/KPV delivery system tested in cells and a mouse colitis model. DOI: 10.1016/j.biomaterials.2016.12.018

Research literature and product documentation are different

A publication describes a study and its results. A batch-specific Certificate of Analysis documents characteristics of a supplied research material. One does not substitute for the other.

Review KPV product specifications · Browse the COA library · Read the research-use policy

Prepared by The Pep Labs Research Editorial Team. This evidence summary is not medical advice and contains no dosing or administration guidance.